Testing effectiveness (Phase 2)Study completedNCT03018275
What this trial is testing
Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis
Who this might be right for
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 31